Loading
companiesCompany
Omanta
Omanta runs a personal research programme for one patient at a time, for people with cancer who have exhausted standard options, coordinating tissue, testing, multi-omic analysis and a treatment strategy with their doctors.
Overview
Omanta is a personalised research lab for individual patients across oncology, rare disease and undiagnosed conditions: it operationalises a patient-specific research programme covering tissue logistics, diagnostic follow-up, data integration, multi-omic analysis and therapeutic strategy development, and acts as a collaborative partner to the treating clinicians with a living evidence roadmap. It is a Summer 2026 YC company with a small team; it is a service rather than a regulated product, and outcomes have not been published.
Headquarters
San Francisco, CA, US
Funding
All startupsStartupYC S26
Investors
Type
Stage
Startup · Y Combinator Summer 2026
Website
Similar pages
- CompanyCambridge Cancer Genomics (CCG.ai)
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyYemaachi Biotech
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyOncobox
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyBillionToOne
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyData Driven Bioscience (Duoseq)
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyAlixia
Shares Y Combinator and the tag yc.